MENICALI, Elisa
MENICALI, Elisa
Dipartimento di Medicina e Chirurgia
Immune Landscape of Thyroid Cancers: New Insights
2021 Menicali, E.; Guzzetti, M.; Morelli, S.; Moretti, S.; Puxeddu, E.
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like
2019 Giannini, R.; Moretti, S.; Ugolini, C.; Macerola, E.; Menicali, E.; Nucci, N.; Morelli, S.; Colella, R.; Mandarano, M.; Sidoni, A.; Panfili, M.; Basolo, F.; Puxeddu, E.
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT.
2014 Moretti, Sonia; Menicali, Elisa; Voce, P; Morelli, Silvia; Cantarelli, S; Sponziello, M; Colella, R; Fallarino, Francesca; Orabona, Ciriana; Alunno, Alessia; de Biase, D; Bini, Vittorio; Mameli, Mg; Filetti, S; Gerli, Roberto; Macchiarulo, A; Melillo, Rm; Tallini, G; Santoro, M; Puccetti, Paolo; Avenia, Nicola; Puxeddu, Efisio
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma
2012 Menicali, Elisa; Moretti, Sonia; Voce, Pasquale; Romagnoli, S; Avenia, Nicola; Puxeddu, Efisio
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1
2017 Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Colella, Renato; Melillo, Rosa Marina; Liotti, Federica; Morelli, Silvia; Fallarino, Francesca; Macchiarulo, Antonio; Santoro, Massimo; Avenia, Nicola; Puxeddu, Efisio
The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition
2020 Moretti, S.; Nucci, N.; Menicali, E.; Morelli, S.; Bini, V.; Colella, R.; Mandarano, M.; Sidoni, A.; Puxeddu, E.
THERAPY of ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: From bench to bedside
2020 Moretti, S.; Menicali, E.; Nucci, N.; Guzzetti, M.; Morelli, S.; Puxeddu, E.
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation
2016 Morelli, S; Reboldi, Gianpaolo; Moretti, Sonia; Menicali, Elisa; Avenia, Nicola; Puxeddu, Efisio
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer
2024 Moretti, Sonia; Mandarano, Martina; Menicali, Elisa; Guzzetti, Martina; Morelli, Silvia; Talpacci, Edoardo; Colella, Renato; Bini, Vittorio; Giannini, Riccardo; Ugolini, Clara; Sidoni, Angelo; Basolo, Fulvio; Puxeddu, Efisio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune Landscape of Thyroid Cancers: New Insights | 2021 | Menicali, E.; Guzzetti, M.; Morelli, S.; Moretti, S.; Puxeddu, E. | |
| Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like | 2019 | Giannini, R.; Moretti, S.; Ugolini, C.; Macerola, E.; Menicali, E.; Nucci, N.; Morelli, S.; Colella, R.; Mandarano, M.; Sidoni, A.; Panfili, M.; Basolo, F.; Puxeddu, E. | |
| INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. | 2014 | Moretti, Sonia; Menicali, Elisa; Voce, P; Morelli, Silvia; Cantarelli, S; Sponziello, M; Colella, R; Fallarino, Francesca; Orabona, Ciriana; Alunno, Alessia; de Biase, D; Bini, Vittorio; Mameli, Mg; Filetti, S; Gerli, Roberto; Macchiarulo, A; Melillo, Rm; Tallini, G; Santoro, M; Puccetti, Paolo; Avenia, Nicola; Puxeddu, Efisio | |
| Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma | 2012 | Menicali, Elisa; Moretti, Sonia; Voce, Pasquale; Romagnoli, S; Avenia, Nicola; Puxeddu, Efisio | |
| Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 | 2017 | Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Colella, Renato; Melillo, Rosa Marina; Liotti, Federica; Morelli, Silvia; Fallarino, Francesca; Macchiarulo, Antonio; Santoro, Massimo; Avenia, Nicola; Puxeddu, Efisio | |
| The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition | 2020 | Moretti, S.; Nucci, N.; Menicali, E.; Morelli, S.; Bini, V.; Colella, R.; Mandarano, M.; Sidoni, A.; Puxeddu, E. | |
| THERAPY of ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: From bench to bedside | 2020 | Moretti, S.; Menicali, E.; Nucci, N.; Guzzetti, M.; Morelli, S.; Puxeddu, E. | |
| Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation | 2016 | Morelli, S; Reboldi, Gianpaolo; Moretti, Sonia; Menicali, Elisa; Avenia, Nicola; Puxeddu, Efisio | |
| Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer | 2024 | Moretti, Sonia; Mandarano, Martina; Menicali, Elisa; Guzzetti, Martina; Morelli, Silvia; Talpacci, Edoardo; Colella, Renato; Bini, Vittorio; Giannini, Riccardo; Ugolini, Clara; Sidoni, Angelo; Basolo, Fulvio; Puxeddu, Efisio |